Reverse iontophoresis: Parameters determining electro-osmotic flow. II. Electrode chamber formulation

Journal of Controlled Release

Volumn 42, Issue 1, 1996, Pages 29-36

  Santi, Patrizia ^a,c   Guy, Richard H ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Ctr Interuniv Rech d'Enseignement   (France)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

Electro osmosis; Iontophoresis; Mannitol; Non invasive monitoring; Percutaneous absorption; Reverse iontophoresis; Skin penetration

Indexed keywords

MANNITOL; NAFARELIN;

ARTICLE; ELECTROOSMOSIS; IONTOPHORESIS; PRIORITY JOURNAL; SKIN ABSORPTION; SKIN PENETRATION;

EID: 0030272432     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-3659(96)01345-4     Document Type: Article

References (21)

1. [1] M. Pikal, The role of electro-osmotic flow in transdermal iontophoresis. Adv. Drug Deliv. Rev. 9 (1992) 201-237.
2. [2] P. Glikfeld, R.S. Hinz and R.H. Guy, Non-invasive sampling of biological fluids by iontophoresis. Pharm. Res. 6 (1989) 988-990.
3. [3] G. Rao, P. Glikfield and R.H. Guy, Reverse iontophoresis: development of a non-invasive approach for glucose monitoring. Pharm. Res. 10 (1993) 1751-1755.
4. [4] S. Numajiri, K. Sugibayashi and Y. Monmoto, Non-invasive sampling of lactic acid ions by iontophoresis using chloride ion in the body as an internal standard. J. Pharm. Biomed. Anal. 11 (1993) 903-909.
5. [5] G. Rao, R.H. Guy, P. Glikfeld, W.R. LaCourse, L. Leung, J. Tamada, R.O. Potts and N. Azimi, Reverse iontophoresis: non-invasive glucose monitoring in vivo in humans. Pharm. Res. 12 (1995) 1869-1873.
6. [6] J.A. Tamada, N.J.V. Bohannon and R.O. Potts, Measurement of glucose in diabetic subjects using non-invasive transdermal extraction. Nature Med. 1 (1995) 1198-1201.
7. [7] A. Kim, P.G. Green, G. Rao and R.H. Guy, Convective solvent flow across the skin during iontophoresis. Pharm. Res. 10 (1993) 1315-1320.
8. [8] M.B. Delgado-Charro and R.H. Guy, Characterization of convective solvent flow during iontophoresis. Pharm. Res. 11 (1994) 929-935.
9. [9] A.J. Hoogstraate, V. Srinivasan, S.M. Sims and W.I. Higuchi, Iontophoretic enhancement of peptides: behavior of Leuprolide versus model permeants. J. Control. Release 31 (1994) 41-47.
10. [10] P. Santi and R.H. Guy, Reverse iontophoresis - parameters determining electro-osmotic flow: I. pH and ionic strength. J. Control. Release 38 (1996) 159-165.
11. [11] P.W. Ledger, Skin biological issues in electrically enhanced transdermal delivery. Adv. Drug Deliv. Rev. 9 (1992) 289-307.
12. [12] P. Glikfeld, R.S. Hinz, C. Cullander and R.H. Guy, A new system for in vitro studies of iontophoresis. Pharm. Res. 5 (1988) 443-446.
13. [13] J.B. Phipps and J.R. Gygory, Transdermal ion migration. Adv. Drug Deliv. Rev. 9 (1992) 137-176.
14. [14] M.B. Delgado-Charro and R.H. Guy, Iontophoretic delivery of Nafarelin across the skin. Int. J. Pharm. 117 (1995) 165-172.
15. [15] R.R. Burnette and B. Ongpipattanakul, Characterization of the permselective properties of excised human skin during iontophoresis. J. Pharm. Sci. 76 (1987) 765-773.
16. [16] W.J. Moore, Physical Chemistry, 5th Edn., Longman Group Ltd., London, 1972, pp. 420-474.
17. [17] C. Cullander, What are the pathways of iontophoretic current through mammalian skin? Adv. Drug Deliv. Rev. 9 (1992) 119-135.
18. [18] C. Cullander and R.H. Guy, Visualization of iontophoretic pathways with confocal microscopy and the vibrating probe electrode. Solid State Ionics 53-56 (1992) 197-206.
19. [19] S.A. Weston and C.R. Parish, Calcein: a novel marker for lymphocytes which enter lymph nodes. Cytometry 13 (1992) 739-749.
20. 2+-heparin complex-formation by polarimetry. Biochem. J. 282 (1992) 601-604.
21. [21] G.P. Hildebrand and C.N. Reilly, New indicator for complexometric titration of calcium in the presence of magnesium. Anal. Chem. 29 (1957) 258.